LINCOLN PHARMACEUTICALS Q2 FY27 ; NET PROFIT UP 2% AT ₹20 CR (YOY), DOWN 44% (QOQ)

REVENUE UP 17% AT ₹191 CR (YOY), UP 8% (QOQ) EBITDA DOWN 7% AT ₹24 CR (YOY), DOWN 14% (QOQ) MARGINS AT 12.4% VS 15.6% (YOY), 15.5% (QOQ)

LINCOLN PHARMA LTD